baker.2480@osu.edu

 Baker
Sharyn Baker
PharmD, PhD
Professor and Gertrude Parker Heer Chair
Pharmaceutics and Pharmaceutical Chemistry
410 Biomedical Research Tower
Phone: 
614-292-3456

Specializations

  • Developmental therapeutics for acute myeloid leukemia
  • Variability in anticancer drug disposition and response

Professional Interests

Dr. Baker’s cancer-relevant research interests broadly cover translational and clinical pharmacology of anti-cancer agents. Recently, her laboratory has focused on the preclinical development of anti-cancer agents for the treatment of acute myeloid leukemia (AML), with an emphasis on tyrosine kinase inhibitor (TKI) drug combinations. Dr. Baker’s research interests include developmental therapeutics for AML, clinical pharmacology of tyrosine kinase inhibitors, variability in anti-cancer drug disposition and investigational anti-cancer drug development.

Lab Members

Daelynn Buelow

Daelynn Buelow, PhD, Research Scientist and Lab Manager

Il-Kyoo ParkIl-Kyoo Park, PhD, Research Scientist

Megan Zavorka ThomasMegan Zavorka Thomas, PhD, Post-Doctoral Researcher

Mingqing (Sophie) ChenMingqing (Sophie) Chen, Pharmaceutics Graduate Research Associate

Jae Yoon (Louis) JeonJae Yoon (Louis) Jeon, PharmD, Translational Science Graduate Research Associate

Education

  • PhD, 2004, Erasmus University The Netherlands
  • PharmD, 1991, University of California at San Francisco, Pharmacy
  • BA, 1986, Pacific Lutheran University, Biology

Honors

  • 2017: ASCPT Clinical and Translational Science Award
  • 2016: Developmental Therapeutics (DT) study section, National Cancer Institute, chartered member
  • 2009-2011: Editorial Board Member, Journal of Clinical Oncology
  • 2008-2014: Xenobiotic and Nutrient Disposition and Action (XNDA) study section, National Institutes of Health, ad hoc reviewer
  • 2008-present: Member, American Society of Hematology
  • 2006-present: Special Emphasis Panel/Scientific Review Group (various), National Institutes of Health, reviewer
  • 2006-2009: Chair, Hematologic and Neoplastic Diseases Scientific Section, American Society for Clinical Pharmacology and Therapeutics
  • 2004–2008: Pharmacology Co-Chair, Developmental Therapeutics Committee, Eastern Cooperative Oncology Group.
  • 2004-present: Member, American Society of Clinical Pharmacology and Therapeutics
  • 1997-present: Member, American Society of Clinical Oncology
  • 1993-present: Member, American Association for Cancer Research

Recent Publications

Recent Publications